Titan Pharmaceuticals
TTNP
#11018
Rank
NZ$10.75 M
Marketcap
NZ$8.09
Share price
-3.76%
Change (1 day)
19.53%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.70. In 2023 the company made an earnings per share (EPS) of NZ-$13.00 an increase over its 2022 EPS that were of NZ-$26.64.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$13.00-51.22%
2022NZ-$26.64-15.61%
2021NZ-$31.57-81.37%
2020NZ-$169.43-77.52%
2019NZ-$753.83-56.32%
2018NZ-$1,726-59.51%
2017NZ-$4,263-371.81%
2016NZ$1,568-144.35%
2015NZ-$3,536300%
2014NZ-$883.97-121.54%
2013NZ$4,104-151.38%
2012NZ-$7,987-11.54%
2011NZ-$9,029188.89%
2010NZ-$3,125-10%
2009NZ-$3,473
2007NZ-$14,238-2.38%
2006NZ-$14,586-39.13%
2005NZ-$23,962-16.87%
2004NZ-$28,824-22.43%
2003NZ-$37,1584.9%
2002NZ-$35,42261.9%
2001NZ-$21,878-13.7%
2000NZ-$25,35165.01%
1999NZ-$15,364-35.87%
1998NZ-$23,958-1824.71%
1997NZ$1,389-102.4%
1996NZ-$57,995

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.32-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.31-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$7.10-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.61-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.42-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.47-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA